Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (131-140 of 10,653) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|January 19, 2018
Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune SystemsOsamu Kanauchi, Akira Andoh, Sazaly AbuBakar, et al.
Current Pharmaceutical Design|January 9, 2018
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysisAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, Sergio D Ascarrunz, et al.
Current Pharmaceutical Design|October 26, 2017
Statins and vulnerable plaqueMaria Drakopoulou, Konstantinos Toutouzas, Archontoula Michelongona, et al.
Current Pharmaceutical Design|October 28, 2017
NTP regeneration and its application in the biosynthesis of nucleotides and their derivativesQingbao Ding, Ling Oua
Current Pharmaceutical Design|October 28, 2017
Epilepsy, Theories and Treatment Inside Corpus HippocraticumGregory Tsoucalas, Konstantinos Spengos, George Panayiotakopoulos, et al.
Current Pharmaceutical Design|October 28, 2017
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic ManagementCharles Vecht, Louis Royer-Perron, Caroline Houillier, et al.
Current Pharmaceutical Design|October 28, 2017
The Prophylactic Use of Antiepileptic Drugs in Patients Scheduled for NeurosurgeryBarbara Miziak, Kinga Borowicz-Reutt, Radoslaw Rola, et al.
Current Pharmaceutical Design|January 16, 2018
Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular PreventionAli Ali, Pierluigi Costanzo, Angela Hoye
Current Pharmaceutical Design|January 16, 2018
Lipoprotein-associated Phospholipase A2 and Coronary Heart DiseaseAreti Sofogianni, Stelina Alkagiet, Konstantinos Tziomalos
Current Pharmaceutical Design|January 17, 2018
Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic SyndromeElena V Galitsyna, Andrey V Zhelankin, Igor A Sobenin, et al.
Pageof 1,066

Showing results (131-140 of 10,653) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|January 19, 2018
Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune SystemsOsamu Kanauchi, Akira Andoh, Sazaly AbuBakar, et al.
Current Pharmaceutical Design|January 9, 2018
Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysisAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, Sergio D Ascarrunz, et al.
Current Pharmaceutical Design|October 26, 2017
Statins and vulnerable plaqueMaria Drakopoulou, Konstantinos Toutouzas, Archontoula Michelongona, et al.
Current Pharmaceutical Design|October 28, 2017
NTP regeneration and its application in the biosynthesis of nucleotides and their derivativesQingbao Ding, Ling Oua
Current Pharmaceutical Design|October 28, 2017
Epilepsy, Theories and Treatment Inside Corpus HippocraticumGregory Tsoucalas, Konstantinos Spengos, George Panayiotakopoulos, et al.
Current Pharmaceutical Design|October 28, 2017
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic ManagementCharles Vecht, Louis Royer-Perron, Caroline Houillier, et al.
Current Pharmaceutical Design|October 28, 2017
The Prophylactic Use of Antiepileptic Drugs in Patients Scheduled for NeurosurgeryBarbara Miziak, Kinga Borowicz-Reutt, Radoslaw Rola, et al.
Current Pharmaceutical Design|January 16, 2018
Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular PreventionAli Ali, Pierluigi Costanzo, Angela Hoye
Current Pharmaceutical Design|January 16, 2018
Lipoprotein-associated Phospholipase A2 and Coronary Heart DiseaseAreti Sofogianni, Stelina Alkagiet, Konstantinos Tziomalos
Current Pharmaceutical Design|January 17, 2018
Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic SyndromeElena V Galitsyna, Andrey V Zhelankin, Igor A Sobenin, et al.
Pageof 1,066